Results of the PROPINE randomized controlled trial: determining the ever-elusive target, the optimal plan for relapses of nephrotic syndrome in children
This study reinforces the need for more well-designed studies and the incorporation of predictive biomarkers, genetic studies, and other details to personalize treatment for each child with idiopathic NS.
Source: Kidney International - Category: Urology & Nephrology Authors: John D. Mahan, Mahmoud Kallash, William E. Smoyer Tags: Commentary Source Type: research